Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-06-18FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction [Phase 1]
Phase 1 pharmacokinetic study of BMS-914143 in participants with normal renal function and mild to end-stage renal dysfunction; the study ha…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B [Phase 4]
Phase 4 trial investigating prophylactic entecavir to prevent hepatitis B reactivation in Non-Hodgkin lymphoma patients with resolved hepati…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections [Phase 4]
Phase 4 long-term immunogenicity study of Engerix-B in 10-year-olds, evaluating the impact of booster injections.
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: Drug Use Investigation for HEPSERA (Adefovir) Tablet
This clinical trial update reports the completion of a Drug Use Investigation for HEPSERA (adefovir dipivoxil) tablets in hepatitis B patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-24Clinical Trial Update: Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students [Phase 4]
Phase 4 completed study assessing hepatitis B seroprevalence and immune response to hepatitis B vaccination among Chinese college students.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination [Phase 4]
Phase 4 study evaluating whether Quinvaxem can be interchanged with other pentavalent vaccines during routine childhood vaccinations; the tr…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection [Phase 4]
Phase 4 clinical trial evaluating intensification of entecavir for persistent HBV viremia in people with HIV-HBV infection; results were pos…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: An Study of Efficacy and Safety of Clevudine [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of clevudine for chronic hepatitis B has been completed.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. [Phase 2]
A Phase 2 trial comparing tenofovir disoproxil fumarate (TDF), emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), and entecavir (ETV) fo…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: PEG-IFN in HBV Patients With Incomplete Response to NA [Phase 4]
Phase 4 trial evaluating pegylated interferon in patients with chronic hepatitis B who have an incomplete response to nucleos(t)ide analogs;…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma [NA]
This clinical trial update describes associations of interleukin-1B and TNF-α gene polymorphisms with HBV-related hepatocellular carcinoma a…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
A completed clinical trial evaluating cccDNA and total HBV DNA kinetics in lymphocytes, total blood, and serum in chronic hepatitis B patien…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT [Phase 4]
Phase 4 clinical trial update evaluating entecavir for chronic hepatitis B patients with persistently normal ALT.
-
FDA approval · 2013-04-16FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine [Phase 3]
Phase 3 trial comparing Tenofovir Disoproxil Fumarate alone versus Emtricitabine/Tenofovir DF in lamivudine-resistant hepatitis B; results p…
-
CLINICAL_TRIALS research · 2013-04-08Clinical Trial Update: Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure
This completed clinical trial evaluates a predictive model for 3-month mortality risk in patients with acute-on-chronic liver failure relate…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Lamivudine and Adefovir to Treat Chronic Hepatitis B [Phase 2]
Phase 2 trial evaluating lamivudine and adefovir for chronic hepatitis B has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B [Phase 3]
This is a Phase 3 randomized trial evaluating whether 48 weeks of pegylated interferon alfa-2a can achieve loss of HBsAg (HBsAg negativation…
-
CLINICAL_TRIALS research · 2013-03-05Clinical Trial Update: Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study [Phase 4]
A Phase 4 pilot trial compares telbivudine plus adefovir versus lamivudine plus adefovir for lamivudine-resistant chronic hepatitis B, with …
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants [Phase 3]
A Phase 3 immunogenicity study evaluating antibody persistence and booster response of the Pentaxim vaccine in healthy Argentinean infants; …
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Suboptimal Responders to Adefovir Switching to Entecavir [Phase 4]
Phase 4 trial update on chronic hepatitis B patients who were suboptimal responders to adefovir and switched to entecavir; results have been…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of Ypeginterferon Alfa-2b in HBeAg-positive chronic hepatitis B has completed. This updat…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
A completed clinical trial assessing how acceptable Hepatitis B vaccination is among general practitioners and pediatricians.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Acceptability of Hepatitis B Vaccination in General Population
A completed clinical trial evaluation of the acceptability of Hepatitis B vaccination in the general population, sponsored by GlaxoSmithKlin…